Added to YB: 2026-04-03
Pitch date: 2026-04-01
NRXS [neutral]
NeurAxis, Inc.
+3.28%
current return
Author Info
Microcap Opportunities is a community dedicated to finding the best opportunities in the MicroCap space for US and Canadian listings primarily. Sign up for the newsletter.
Company Info
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
Market Cap
$82.8M
Pitch Price
$7.02
Price Target
N/A
Dividend
N/A
EV/EBITDA
-11.12
P/E
-7.80
EV/Sales
21.92
Sector
Health Care Equipment and Supplies
Category
growth
NeurAxis: What a CPT Category I Code Actually Does to a Stock
NRXS (update): Cat I CPT code (64567) effective Jan 1 w/ national CMS pricing + exempt from -2.5% RVU cut. Only FDA-cleared device for pediatric IBS/FAP + adult functional dyspepsia; monopoly w/ no competitors. Q1 PA requests 10x vs Q1'25. Covered lives 4M→100M. Comps (INSP, AXNX, SWAV) w/ Cat I + monopoly saw 42-441% 3yr revenue CAGR. TAM $12B vs $107M mkt cap (112x). Stock +80% since Jan 1; Q1 earnings in May = inflection catalyst.
Read full article (5 min)